Clinical Trial Update: Stereotactic Body Radiotherapy for the Treatment of OPD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update of stereotactic body radiotherapy for non-small cell lung cancer in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: NSCLC | Phase 2, Phase 3 | Status: UNKNOWN